Abstract | BACKGROUND: METHODS: A retrospective review of patient data for 15 infants diagnosed with PNALD between December 2012 and August 2013 was performed. PNALD was defined as the presence of 2 consecutive direct bilirubin (DB) levels >2 mg/dL. Fractionated serum alkaline phosphatase was measured in each patient, while the DB was >2 mg/dL. Parathyroid hormone (PTH), vitamin D3, calcium, and phosphate levels were recorded where available. RESULTS: In 15 infants with PNALD, elevation in total ALP was due to marked elevations in bone-specific ALP. The median liver-specific ALP remained within the normal range. PTH, vitamin D3, calcium, and phosphate levels were within normal limits. CONCLUSION: While elevated ALP can reflect biliary stasis, the ALP elevation observed in infants with IF and PNALD is predominantly of bone rather than hepatic origin. An elevated unfractionated ALP in infants with PNALD should therefore raise suspicion of underlying bone disease, rather than being attributed to liver disease alone.
|
Authors | Prathima Nandivada, Alexis K Potemkin, Sarah J Carlson, Melissa I Chang, Eileen Cowan, Alison A O'Loughlin, Kathleen M Gura, Mark Puder |
Journal | JPEN. Journal of parenteral and enteral nutrition
(JPEN J Parenter Enteral Nutr)
Vol. 39
Issue 8
Pg. 973-6
(Nov 2015)
ISSN: 1941-2444 [Electronic] United States |
PMID | 25106918
(Publication Type: Evaluation Study, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Copyright | © 2014 American Society for Parenteral and Enteral Nutrition. |
Chemical References |
- Alkaline Phosphatase
- Bilirubin
|
Topics |
- Alkaline Phosphatase
(blood)
- Bilirubin
(blood)
- Bone Diseases, Metabolic
(blood, diagnosis)
- Bone and Bones
(metabolism, pathology)
- Humans
- Infant
- Intestinal Diseases
(therapy)
- Liver
(metabolism, pathology)
- Liver Diseases
(blood, diagnosis, etiology)
- Liver Function Tests
- Parenteral Nutrition
(adverse effects)
- Retrospective Studies
|